VTRS vs XENE · rev $7.27B vs $2.55B cap
Viatris Inc (VTRS) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
VTRS currently screens at market cap $10.83B. XENE currently screens at market cap $2.55B.
Not investment advice. Open the VTRS and XENE stock pages for the full models.
Not investment advice.